His primary areas of investigation include Adenosine, Neuroscience, Internal medicine, Endocrinology and Adenosine A2A receptor. His biological study spans a wide range of topics, including Extracellular, Adenosine A1 receptor, Adenosine receptor, Neurotransmission and Pharmacology. His Adenosine A1 receptor research is multidisciplinary, incorporating perspectives in Adenosine A3 receptor, Biophysics, Purinergic signalling, Adenosine deaminase and Receptor antagonist.
His studies in Neuroscience integrate themes in fields like Synaptic plasticity, Receptor, Glutamatergic and Glutamate receptor. His research integrates issues of Agonist, Antagonist and Microglia in his study of Endocrinology. His Adenosine A2A receptor research integrates issues from Alzheimer's disease, Forebrain, Dopamine receptor D2 and Chronic stress.
Neuroscience, Internal medicine, Endocrinology, Adenosine and Adenosine A2A receptor are his primary areas of study. His Neuroscience research includes themes of Synaptic plasticity, Receptor and Long-term potentiation. His Endocrinology research is multidisciplinary, relying on both Agonist, CGS-21680, Adenosine receptor antagonist and Antagonist.
The various areas that Rodrigo A. Cunha examines in his Adenosine study include Adenosine A1 receptor, Purinergic signalling, Adenosine receptor and Receptor antagonist. His research in Adenosine A1 receptor intersects with topics in Extracellular, Adenosine A3 receptor and Adenosine deaminase. His studies in Adenosine A2A receptor integrate themes in fields like SCH-58261, Glutamate receptor, Neuroprotection, Pharmacology and Dopamine.
Rodrigo A. Cunha spends much of his time researching Neuroscience, Adenosine A2A receptor, Adenosine, Internal medicine and Endocrinology. His work carried out in the field of Neuroscience brings together such families of science as Synaptic plasticity, Long-term potentiation and Neurotransmission. His work deals with themes such as Neurodegeneration, Microglia, Neuroprotection, Dopamine and Knockout mouse, which intersect with Adenosine A2A receptor.
His Adenosine research integrates issues from Receptor, Adenosine A1 receptor, Adenosine receptor and Cell biology. In his study, Neuroplasticity, Water maze and Impulsivity is inextricably linked to Attention deficit hyperactivity disorder, which falls within the broad field of Internal medicine. His Open field study in the realm of Endocrinology connects with subjects such as Binge drinking.
His primary areas of investigation include Neuroscience, Adenosine A2A receptor, Long-term potentiation, Adenosine and Hippocampal formation. His Neuroscience study combines topics in areas such as Excitotoxicity and Neurodegeneration. His Adenosine A2A receptor research includes elements of Glutamate receptor, Adenosine A1 receptor, Cognition, Microglia and Neuroprotection.
Rodrigo A. Cunha combines subjects such as Synaptic plasticity and Hippocampus with his study of Long-term potentiation. His Hippocampus study falls within the topics of Endocrinology and Internal medicine. His Adenosine research includes themes of Receptor, Pharmacology and Adenosine receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adenosine and Brain Function
Bertil B Fredholm;Jiang-Fan Chen;Rodrigo A Cunha;Per Svenningsson.
International Review of Neurobiology (2005)
Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors
Neurochemistry International (2001)
Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers
Francisco Ciruela;Vicent Casadó;Ricardo J. Rodrigues;Rafael Luján.
The Journal of Neuroscience (2006)
Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
Paula Agostinho;Rodrigo A. Cunha;Catarina Oliveira.
Current Pharmaceutical Design (2010)
Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
Rodrigo A. Cunha.
Purinergic Signalling (2005)
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
Catarina V. Gomes;Manuella P. Kaster;Angelo R. Tomé;Paula M. Agostinho.
Biochimica et Biophysica Acta (2011)
Adenosine A2A receptors and basal ganglia physiology.
Serge N. Schiffmann;Gilberto Fisone;R Moresco;Rodrigo Antunes Cunha.
Progress in Neurobiology (2007)
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
Oscar P. Dall'Igna;Paulo Fett;Marcio W. Gomes;Diogo O. Souza.
Experimental Neurology (2007)
Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses.
Nelson Rebola;Rafael Lujan;Rodrigo A. Cunha;Christophe Mulle.
How does adenosine control neuronal dysfunction and neurodegeneration
Rodrigo A. Cunha.
Journal of Neurochemistry (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: